A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $17.5 | $219.9 | 10% |
|
| Shares Out (Mil) | 2.8 | 54.1 | 10% |
|
| Institutional Ownership | 89.5% | 92.9% | 57% |
|
| Float (Mil) | 4.6 | 41.4 | 12% |
|
| Beta | 1.73 | 0.95 | 87% |
|
| Avg Daily Volume (000s) | 15 | 522 | 20% |
|
| Price Change (52-week) |
(62.2%) | 44.7% | 15% |
|
| Growth | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.2% | na |
|
| Net Income (5yr) | (49.7%) | (10.1%) | 7% |
|
| EPS (5yr) | na | 15.8% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.7%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($1.760) | ($7.170) | ($3.185) | |
| Month Ago EPS | ($1.760) | ($7.170) | ($3.185) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | ($1.685) | ($6.880) | ($2.910) | |
| Year/Year Chg | (7.2%) | (51.5%) | (94.0%) | |
| Financials | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $38 | na |
|
| Net Income (TTM) (Mil) | ($19) | ($44) | 24% |
|
| EPS (TTM) | ($8.521) | ($1.500) | 5% |
|
| Operating Cash Flow (TTM) (Mil) | ($15) | ($35) | 17% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $0 | 49% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $4 | 18% |
|
| Enterprise Value (Q1) (Mil) | $24 | $166 | 12% |
|
| Valuation | QNRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.86 | 2.06 | 52% |
|
| P/E | na | 16.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.3% | na |
|
| Net Margin | na | (61.0%) | na |
|
| ROA | (178.8%) | (47.5%) | 2% |
|
| ROE | (575.7%) | (52.7%) | 1% |
|
| Liabilities to Assets | 67.1% | 29.6% | 63% |
|
| F-Score | 1 | 3 | 1% |
|
Quoin Pharmaceuticals, Ltd. did not pass any screens on 11/6/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
